MUC1 and neoplasm: For example, it has higher tumor specificity and affinity with an increased number of binding sites, reduced binding to shed MUC1 from colon and pancreatic carcinoma, no binding to peripheral blood mononucleated cells, stronger ADCC, and rapid internalization compared to other antibodies [95].